Spark Therapeutics (ONCE) to be Acquired by Roche for $114.50/Share
February 25, 2019 6:10 AM
Spark Therapeutics (NASDAQ: ONCE), a fully integrated, commercial gene therapy company dedicated to challenging the inevitability of genetic disease, announced ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
